Goldshield settles £1m 'price-fixing' claim
Thursday 06 March 2008
The drug company Goldshield, which is accused of fixing the price of medicines supplied to the NHS, has agreed to pay £1m to settle claims brought by the health authorities of Northern Ireland and Scotland.
Without admission of liability and on a "full and final basis", Goldshield yesterday agreed to pay £250,000 to the Department of Health and Social Services of Northern Ireland, a day after settling its claim with the Scottish authorities for £750,000.
The move comes eight months after the company paid the NHS £4m to settle its claims relating to the price-fixing of generic medicine bringing the total paid out by the company to £5m.
The civil claims accused a number of drug companies of operating a cartel and colluding to fix the price of warfarin, a blood-thinning drug.
Keith Hellawell, chairman of Goldshield, said he was pleased to have reached a settlement with the different authorities. "We recognise the importance of building strong working relationships with our customers," he said.
The Scottish Health Secretary Nicola Sturgeon said: "I am delighted we have managed to reach a settlement agreement with Goldshield. This is a satisfactory conclusion to our negotiations."
Shares in the company rose 4.5p yesterday to 274p.
The Serious Fraud Office (SFO) is continuing with its criminal investigation relating to allegations concerning warfarin and penicillin-based antibiotics supplied to the NHS between January 1996 and December 2000. As part of an inquiry into the alleged multimillion-pound scam, police raided six drug companies in 2002.
The company's former chief executive and co-founder, Ajit Patel, and Kirti Patel, chief operating officer, resigned from the company last summer to focus on the criminal case and former finance director Rakesh Patel became chief executive.
At the time of the company's interim results in September, Dr Hellawell said Goldshield remained in positive dialogue with the SFO. If the case were to end in a trial, Goldshield could face a fine of £5m to £6m if found guilty, according to analysts.
The group reported half-year pre-tax profit of £6.1m in September compared with losses of £3.6m the same period the previous year. The company has changed its strategy to focus on its core pharmaceutical and healthcare business after agreeing to sell off its India business.
- 1 I've been called an abusive and dangerous parent, when all I did was listen to my transgender child
- 2 Why this father didn’t hide his daughter’s heroin overdose in her obituary
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
- 4 Teaching profession headed for crisis as numbers continue to drop and working lives become 'unbearable'
- 5 The most powerful passports in the world
Nepal earthquake in pictures: Photos show devastation caused by 7.8 magnitude earthquake
Smartphones are making children borderline autistic, says psychiatrist
Nepal earthquake: The race is on to help thousands trapped under rubble around Kathmandu, while remote villages face a long wait for help
Royal baby: Live updates as superbug closes ward at St Mary's Hospital where Duchess of Cambridge is due to give birth
Teaching profession headed for crisis as numbers continue to drop and working lives become 'unbearable'
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband
The sickening truth about food banks that the Tories don't want you to know
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
Rupert Murdoch berated Sun journalists for not doing enough to attack Ed Miliband and stop him winning the general election
iJobs Money & Business
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...